The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Open Access
- 15 July 1997
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 100 (2), 264-269
- https://doi.org/10.1172/jci119531
Abstract
The angiotensin AT2 receptor modulates renal production of cyclic guanosine 3',5'-monophosphate (cGMP; J. Clin. Invest. 1996. 97:1978-1982). In the present study, we hypothesized that angiotensin II (Ang II) acts at the AT2 receptor to stimulate renal production of nitric oxide leading to the previously observed increase in cGMP. Using a microdialysis technique, we monitored changes in renal interstitial fluid (RIF) cGMP in response to intravenous infusion of the AT2 receptor antagonist PD 123319 (PD), the AT1 receptor antagonist Losartan, the nitric oxide synthase (NOS) inhibitor nitro--arginine-methyl-ester (-NAME), the specific neural NOS inhibitor 7-nitroindazole (7-NI), or Ang II individually or combined in conscious rats during low or normal sodium balance. Sodium depletion significantly increased RIF cGMP. During sodium depletion, both PD and -NAME caused a similar decrease in RIF cGMP. Combined administration of PD and -NAME decreased RIF cGMP to levels observed with PD or -NAME alone or during normal sodium intake. During normal sodium intake, Ang II caused a twofold increase in RIF cGMP. Neither PD nor -NAME, individually or combined, changed RIF cGMP. Combined administration of Ang II and either PD or -NAME produced a significant decrease in RIF cGMP compared with that induced by Ang II alone. Combined administration of Ang II, PD, and -NAME blocked the increase in RIF cGMP produced by Ang II alone. During sodium depletion, 7-NI decreased RIF cGMP, but the reduction of cGMP in response to PD alone or PD combined with 7-NI was greater than with 7-NI alone. During normal sodium intake, 7-NI blocked the Ang II-induced increase in RIF cGMP. PD alone or combined with 7-NI produced a greater inhibition of cGMP than did 7-NI alone. During sodium depletion, 7-NI (partially) and -NAME (completely) inhibited RIF cGMP responses to -arginine. These data demonstrate that activation of the renin- angiotensin system during sodium depletion increases renal nitric oxide production through stimulation by Ang II at the angiotensin AT2 receptor. This response is partially mediated by neural NOS, but other NOS isoforms also contribute to nitric oxide production by this pathway.Keywords
This publication has 20 references indexed in Scilit:
- Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal HemodynamicsHypertension, 1996
- The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.JCI Insight, 1996
- Endothelial AT 1 –Mediated Release of Nitric Oxide Decreases Angiotensin II Contractions in Rat Carotid ArteryHypertension, 1995
- Renal Interstitial Fluid AngiotensinHypertension, 1995
- Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats.JCI Insight, 1995
- Expression of Immunoreactive Nitric Oxide Synthase Isoforms in Rat Kidney. Effects of Dietary Salt and Losartan.Japanese Heart Journal, 1995
- Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidneyKidney International, 1994
- Identification of imidazole as l‐arginine‐competitive inhibitor of porcine brain nitric oxide synthaseFEBS Letters, 1994
- Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake.Hypertension, 1994
- Contribution of the renin-angiotensin system to the control of intrarenal hemodynamicsKidney International, 1984